mPhase Technologies, Inc. Continues to Position Scalable Smart Reserve Cell Technology for 2011 Federal Funding
News Jan 04, 2011
Scalable Smart Reserve Cell Technology was listed to receive funding as part of the omnibus appropriations bill that failed to achieve a bipartisan compromise in the United States Senate in December of 2010, as part of the budget for the current 2011 fiscal year. Nevertheless, the Company is actively seeking to have such line item funding reintroduced in January of 2011, as part of early consideration in a defense appropriations bill for the 2011 fiscal year, and it is anticipated that it should be a high-priority item for the next Congress to augment to the temporary resolution that is currently funding the U.S. government.
"We are encouraged that the prior Congress has recognized the importance of this technology," said Mr. Ronald Durando, mPhase's President and Chief Executive Officer. The bill that was passed by the House of Representative in the last Congressional session is the first time Congress specifically designated funding for this type of technology. The Company continues to believe that it will be well positioned for a defense appropriations line item in the next Congress that convenes in January of 2011, given the company's leadership in the field.
The company is a leader in developing new innovative products using micro fluid dynamics, MEMS and super-hydrophobic suspension and separation of liquids on micro structures of silicon, developed through the science of nanotechnology. mPhase began using nanotechnology to develop power cells in 2004 with the Bell Labs division of Alcatel-Lucent (formerly Lucent Technologies, Inc.)
The Company has successfully delivered to the United States Army under a Phase II STTR grant a prototype of its Smart NanoBattery. "We believe that the successful delivery of a prototype of a first of its kind reserve battery designed for backup power for critical mission computer memory is vital in strategic weapons systems and sensor networks," said Durando. The company is positioned to custom tailor its Smart NanoBattery for a variety of military subsystems and critical mission commercial products. The Company is in the process of applying for new Phase I grants under both STTR and SBIR programs promulgated by the United States Department of Defense and the United States Department of Energy, as well as National Science Foundation grants.
By leveraging an organ-on-a-chip model and a bioreactor, four human gut metabolites have been identified that can help explain the enhanced sensitivity of the human colon towards enterohemorrhagic E. coli, which is responsible for more than 100,000 infections per year in the USA alone.READ MORE